Ausgabe 5/2023
Inhalt (17 Artikel)
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis
Ennio Lubrano, Silvia Scriffignano, Fabio Massimo Perrotta
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis
Bruce W. Kirkham, Alexander Egeberg, Frank Behrens, Andreas Pinter, Joseph F. Merola, Thorsten Holzkämper, Gaia Gallo, Khai Jing Ng, Rebecca Bolce, Christopher Schuster, Peter Nash, Luis Puig
Infections in Biological and Targeted Synthetic Drug Use in Rheumatoid Arthritis: Where do We Stand? A Scoping Review and Meta-analysis
Barbara J. M. Bergmans, Biniyam Y. Gebeyehu, Eugène P. van Puijenbroek, Katrijn Van Deun, Bennett Kleinberg, Jean-Luc Murk, Esther de Vries
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK
Heide A. Stirnadel-Farrant, Sarowar M. Golam, Barbara Naisbett-Groet, Danny Gibson, Julia Langham, Sue Langham, Mihail Samnaliev
Comparison of the Effectiveness and Safety of Mycophenolate Mofetil and Cyclophosphamide in Lupus Nephritis: Evidence from a Real-World Study
Xiaohui Zhang, Hong Huang, Dai Gao, Juan Zhao, Lanlan Ji, Yong Fan, Yanjie Hao, Zhuoli Zhang
Management of Specific Clinical Profiles in Axial Spondyloarthritis: An Expert’s Document Based on a Systematic Literature Review and Extended Delphi Process
Rosario García-Vicuña, Xavier Juanola, Victoria Navarro-Compán, Manuel José Moreno-Ramos, Concepción Castillo-Gallego, Mireia Moreno, Eva Galíndez, María Montoro, Ismael Gómez, Francisco Jose Rebollo-Laserna, Estíbaliz Loza
Racial and Ethnic Disparities in Treatment Initiation Among Patients with Newly Diagnosed Psoriatic Arthritis: A Retrospective Medicaid Claims Database Study
Aarti A. Patel, Shannon Allen Ferrante, Iris Lin, Alex Z. Fu, Alicia K. Campbell, Arlene Tieng
Post-Marketing Safety Surveillance of Tofacitinib over 9 Years in Patients with Psoriatic Arthritis and Rheumatoid Arthritis
Gerd R. Burmester, Laura C. Coates, Stanley B. Cohen, Yoshiya Tanaka, Ivana Vranic, Edward Nagy, Irina Lazariciu, All-shine Chen, Kenneth Kwok, Lara Fallon, Cassandra Kinch
The Impact of Label Changes (Boxed Warning) on Real-World Febuxostat Utilization in Patients with Gout: A Cross-Sectional Drug Utilization Study
Alexandra Z. Sosinsky, Yufei Song, Lhanoo Gunawardhana, Syd Phillips, Matt Page
Is the Rate of Responders to Hyaluronic Acid Injection for Patients with Knee Osteoarthritis Stable Over Time? Post hoc Analyses of a 6-Month Follow-Up Study
Olivier Bruyere, Germain Honvo, Eduard Vidovic, Bernard Cortet
Real-World Immunosuppressant Treatment Patterns for Patients with Lupus Nephritis in the United States
Jacob N. Hunnicutt, Mary Elizabeth Georgiou, Liyuan Ma, Roger A. Levy, Kerry Gairy
Persistence and Use of Ixekizumab in Patients with Psoriatic Arthritis in Real-World Practice in Spain. The PRO-STIP Study
Beatriz Joven, Raquel Hernández Sánchez, Eva Pérez-Pampín, Ángel Aragón Díez, Raquel Almodóvar, Ángels Martínez-Ferrer, Joaquín Belzunegui, Esteban Rubio, Silvia Díaz-Cerezo, Sebastián Moyano, Manuel Gómez-Barrera, María Yébenes, Mercedes Núñez
Filgotinib Modulates Inflammation-Associated Peripheral Blood Protein Biomarkers in Adults with Active Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate
Yoshiya Tanaka, Peter C. Taylor, Emon Elboudwarej, Angie Hertz, Xiaorong Shao, Vladislav A. Malkov, Hironori Matsushima, Kahaku Emoto, Bryan Downie, Tsutomu Takeuchi
Patients’ Needs Concerning Patient Education in Axial Spondyloarthritis: A Qualitative Study
Yvonne M. van der Kraan, Davy Paap, Niels Lennips, Else C. A. Veenstra, Freke R. Wink, Stan C. Kieskamp, Anneke Spoorenberg
PDCD5 as a Potential Biomarker for Improved Prediction of the Incidence and Remission for Patients with Rheumatoid Arthritis
Juan Xiao, Fengqiao Zhou, Zhenwang Zhao, Fengsheng Cao, Hong Xiao, Lu Zhang, Huabo Chen, Ke Wang, Anbing Zhang
Clinical and Economic Benefit of Advanced Therapies for the Treatment of Active Ankylosing Spondylitis
Jessica A. Walsh, Christopher D. Saffore, Eric B. Collins, Andrew Ostor